WSO-GAINS-ESO Early Investigator Workshop The course will be held on Tuesday, 22 October 2024 from 12pm to 5pm. All participants of the pre-congress workshop must be registered for WSC 2024. То confirm your participation, tick the registration form box indicating you will attend the course. This highly acclaimed interactive workshop is a unique opportunity to get feedback on your research ideas and debate common challenges with peers and mentors. We welcome early-career researchers from all disciplines to bring a short abstract highlighting their research. Full story

The Neuro-EM Program is currently accepting applications for its inaugural scholar cohort as well as nominations for its Pipeline Program. Scholar applications and Pipeline nominations are due October 1, 2024. Click Full Story for more information Full story

Steven M. Greenberg, Wendy C. Ziai, Charlotte Cordonnier, Dar Dowlatshahi, Brandon Francis, Joshua N. Goldstein, J. Claude Hemphill III, Ronda Johnson, Kiffon M. Keigher, William J. Mack, J. Mocco, Eileena J. Newton, Ilana M. Ruff, Lauren H. Sansing, Sam Schulman, Magdy H. Selim, Kevin N. Sheth, Nikola Sprigg, Katharina S. Sunnerhagen, and on behalf of the American Heart Association/American Stroke Association, Published May 17, 2022 Full story

Ashkan Shoamanesh, Magdy Selim, Published June 6, 2022 Full story

Kevin N. Sheth, MD, Magdy Selim, MD, PhD, Published June 27, 2022 Full story

The primary concern for StrokeNet is the safety of our patients or potential patients for our ongoing trials. The second concern is the safety of our own investigators and study team members. Finally, we also want to maintain, as much as possible, the integrity of the trials to potentially benefit patients and so that the data can be used to answer the questions that the trials intended. This latter point is critical for subjects in the trial and those with the specific problem in the future. However, immediate safety issues take priority over any formal processes in ongoing trials. For example, while a current protocol may specify that a study visit needs to be in person, the FDA has guidance about the primary safety of study subjects: For more information click Full Story: Full story

The National Institute of Neurological Disorders and Stroke (NINDS), and National Institutes of Health (NIH) recently assembled an external working group of international experts to update the Stroke v1.0 Common Data Elements (CDEs) based on user feedback and research advances. Full story